Clinical Trial Update: Study of Palifosfamide-tris in Combination With Doxorubicin in Patients With Front-line Metastatic Soft Tissue Sarcoma [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating Palifosfamide-tris in combination with doxorubicin as first-line therapy for metastatic soft tissue sarcoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Palifosfamide Tris (palifosfamide tris)

Snippet

Sponsor: Alaunos Therapeutics | Conditions: Soft Tissue Sarcoma | Phase 3 | Status: COMPLETED